|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sedlis A, Bundy BN, Rotman MZ, Lentz SS,
Muderspach LI and Zaino RJ: A randomized trial of pelvic radiation
therapy versus no further therapy in selected patients with stage
IB carcinoma of the cervix after radical hysterectomy and pelvic
lymphadenectomy: A gynecologic oncology group study. Gynecol Oncol.
73:177–183. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Monk BJ, Wang J, Im S, Stock RJ, Peters WA
III, Liu PY, Barrett RJ II, Berek JS, Souhami L, Grigsby PW, et al:
Rethinking the use of radiation and chemotherapy after radical
hysterectomy: A clinical-pathologic analysis of a gynecologic
oncology group/southwest oncology group/radiation therapy oncology
group trial. Gynecol Oncol. 96:721–728. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rotman M, Sedlis A, Piedmonte MR, Bundy B,
Lentz SS, Muderspach LI and Zaino RJ: A phase III randomized trial
of postoperative pelvic irradiation in Stage IB cervical carcinoma
with poor prognostic features: Follow-up of a gynecologic oncology
group study. Int J Radiat Oncol Biol Phys. 65:169–176. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Eifel PJ, Winter K, Morris M, Levenback C,
Grigsby PW, Cooper J, Rotman M, Gershenson D and Mutch DG: Pelvic
irradiation with concurrent chemotherapy versus pelvic and
para-aortic irradiation for high-risk cervical cancer: An update of
radiation therapy oncology group trial (RTOG) 90–01. J Clin Oncol.
22:872–880. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Legge F, Chiantera V, Macchia G, Fagotti
A, Fanfani F, Ercoli A, Gallotta V, Morganti AG, Valentini V,
Scambia G and Ferrandina G: Clinical outcome of recurrent locally
advanced cervical cancer (LACC) submitted to primary multimodality
therapies. Gynecol Oncol. 138:83–88. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
De Benedetti A and Graff JR: eIF4E
expression and its role in malignancies and metastases. Oncogene.
23:3189–3199. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Graff JR, Konicek BW, Carter JH and
Marcusson EG: Targeting the eukaryotic translation initiation
factor 4E for cancer therapy. Cancer Res. 68:631–634. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liang S, Zhou Y, Chen Y, Ke G, Wen H and
Wu X: Decreased expression of EIF4A1 after preoperative
brachytherapy predicts better tumor-specific survival in cervical
cancer. Int J Gynecol Cancer. 24:908–915. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shuda M, Kondoh N, Tanaka K, Ryo A,
Wakatsuki T, Hada A, Goseki N, Igari T, Hatsuse K, Aihara T, et al:
Enhanced expression of translation factor mRNAs in hepatocellular
carcinoma. Anticancer Res. 20:2489–2494. 2000.PubMed/NCBI
|
|
12
|
Eberle J, Krasagakis K and Orfanos CE:
Translation initiation factor eIF-4A1 mRNA is consistently
overexpressed in human melanoma cells in vitro. Int J Cancer.
71:396–401. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bordeleau ME, Robert F, Gerard B,
Lindqvist L, Chen SM, Wendel HG, Brem B, Greger H, Lowe SW, Porco
JA Jr and Pelletier J: Therapeutic suppression of translation
initiation modulates chemosensitivity in a mouse lymphoma model. J
Clin Invest. 118:2651–2660. 2008.PubMed/NCBI
|
|
14
|
Pecorelli S: Revised FIGO staging for
carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol
Obstet. 105:103–104. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Puck TT and Marcus PI: Rapid method for
viable cell titration and clone production with HELA cells in
tissue culture: The use of X-irradiated cells to supply
conditioning factors. Proc Natl Acad Sci USA. 41:pp. 432–437. 1955;
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Puck TT and Marcus PI: Action of X rays on
mammalian cells. J Exp Med. 103:653–666. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Linder P, Tanner NK and Banroques J: From
RNA helicases to RNPases. Trends Biochem Sci. 26:339–341. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cordin O, Banroques J, Tanner NK and
Linder P: The DEAD-box protein family of RNA helicases. Gene.
367:17–37. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pyle AM: Translocation and unwinding
mechanisms of RNA and DNA helicases. Annu Rev Biophys. 37:317–336.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Abdelhaleem M: Do human RNA helicases have
a role in cancer? Biochim Biophys Acta. 1704:37–46. 2004.PubMed/NCBI
|
|
21
|
Kozak M: An analysis of 5′-noncoding
sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res.
15:8125–8148. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ji P, Diederichs S, Wang W, Böing S,
Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, et
al: MALAT-1, a novel noncoding RNA, and thymosin beta4 predict
metastasis and survival in early-stage non-small cell lung cancer.
Oncogene. 22:8031–8041. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Painter RB: DNA damage and repair in
eukaryotic cells. Genetics. 78:139–148. 1974.PubMed/NCBI
|
|
24
|
O'Neill P and Wardman P: Radiation
chemistry comes before radiation biology. Int J Radiat Biol.
85:9–25. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nocentini S: Rejoining kinetics of DNA
single- and double-strand breaks in normal and DNA ligase-deficient
cells after exposure to ultraviolet C and gamma radiation: an
evaluation of ligating activities involved in different DNA repair
processes. Radiat Res. 151:423–432. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jeggo PA and Löbrich M: How cancer cells
hijack DNA double-strand break repair pathways to gain genomic
instability. Biochem J. 471:1–11. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Iliakis G, Wang H, Perrault AR, Boecker W,
Rosidi B, Windhofer F, Wu W, Guan J, Terzoudi G and Pantelias G:
Mechanisms of DNA double strand break repair and chromosome
aberration formation. Cytogenet Genome Res. 104:14–20. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mladenov E and Iliakis G: Induction and
repair of DNA double strand breaks: The increasing spectrum of
non-homologous end joining pathways. Mutat Res. 711:61–72. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sánchez-Flores M, Pásaro E, Bonassi S,
Laffon B and Valdiglesias V: γH2AX assay as DNA damage biomarker
for human population studies: Defining experimental conditions.
Toxicol Sci. 144:406–413. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hamer G, Roepers-Gajadien HL, van
Duyn-Goedhart A, Gademan IS, Kal HB, van Buul PP and de Rooij DG:
DNA double-strand breaks and gamma-H2AX signaling in the testis.
Biol Reprod. 68:628–634. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Paull TT, Rogakou EP, Yamazaki V,
Kirchgessner CU, Gellert M and Bonner WM: A critical role for
histone H2AX in recruitment of repair factors to nuclear foci after
DNA damage. Curr Biol. 10:886–895. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sedelnikova OA, Rogakou EP, Panyutin IG
and Bonner WM: Quantitative detection of (125)IdU-induced DNA
double-strand breaks with gamma-H2AX antibody. Radiat Res.
158:486–492. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pilch DR, Sedelnikova OA, Redon C, Celeste
A, Nussenzweig A and Bonner WM: Characteristics of gamma-H2AX foci
at DNA double-strand breaks sites. Biochem Cell Biol. 81:123–129.
2003. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Rogakou EP, Boon C, Redon C and Bonner WM:
Megabase chromatin domains involved in DNA double-strand breaks in
vivo. J Cell Biol. 146:905–916. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nazarov IB, Smirnova AN, Krutilina RI,
Svetlova MP, Solovjeva LV, Nikiforov AA, Oei SL, Zalenskaya IA, Yau
PM, Bradbury EM and Tomilin NV: Dephosphorylation of histone
gamma-H2AX during repair of DNA double-strand breaks in mammalian
cells and its inhibition by calyculin A. Radiat Res. 160:309–317.
2003. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Svetlova M, Solovjeva L, Nishi K, Nazarov
I, Siino J and Tomilin N: Elimination of radiation-induced
gamma-H2AX foci in mammalian nucleus can occur by histone exchange.
Biochem Biophys Res Commun. 358:650–654. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Solovjeva LV, Pleskach NM, Firsanov DV,
Svetlova MP, Serikov VB and Tomilin NV: Forskolin decreases
phosphorylation of histone H2AX in human cells induced by ionizing
radiation. Radiat Res. 171:419–424. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Löbrich M, Shibata A, Beucher A, Fisher A,
Ensminger M, Goodarzi AA, Barton O and Jeggo PA: gammaH2AX foci
analysis for monitoring DNA double-strand break repair: Strengths,
limitations and optimization. Cell Cycle. 9:662–669. 2010.
View Article : Google Scholar : PubMed/NCBI
|
